Overall Survival Of Cetuximab Administered Every Two Weeks Versus Weekly In Real-World Data Of Us Patients With Metastatic Colorectal Cancer

Chris Pescott,Michael Batech,Emmanuelle Boutmy,Philippe Ronga,Francois-Xavier Lamy

JOURNAL OF CLINICAL ONCOLOGY（2020）

引用 2|浏览7

暂无评分

摘要

23Background: Cetuximab (CET) administered weekly (q1w) at 250 mg/m², after an initial dose of 400 mg/m², is approved in combination with chemotherapy (CT) for the treatment of (K)RAS wild-type met...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要